JNGLX Fees and Costs — Janus Henderson Global Life Sciences Fund, Class D
Data updated: 2026-08-26
The net expense ratio is 0.81%: a 0.64% management fee plus 0.17% other expenses. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $1.3M in broker commissions, 0.0261% of average net assets, and portfolio turnover was 30%.
JNGLX Fees and Expenses
Annual operating expenses and sales charges of JNGLX. Prospectus, as of September 30, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.64% |
| 12b-1 fee | — |
| Other expenses | 0.17% |
| Gross expense ratio | 0.81% |
| Fee waiver | — |
| Net expense ratio | 0.81% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
JNGLX Costs Over Time
On $10,000 invested in JNGLX, assuming 5% a year before costs, total costs come to $525 over 5 years, cutting the return by 0.88% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.81%) | $85 | $266 | $462 |
| Trading costs (broker commissions) | $3 | $9 | $15 |
| Lost growth on money paid in costs | $0 | $14 | $48 |
| Total costs | $88 | $288 | $525 |
| Value after costs | $10,412 | $11,288 | $12,238 |
| Impact on return, per year | 0.88% | 0.88% | 0.88% |
JNGLX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.0261%
- Total broker commissions: $1.3M
- Bought from dealers (principal trades, not a cost): $185.5M
- Portfolio turnover (prospectus): 30%
- Securities on loan, average value: $14.0M
- Net income from securities lending: $145K (0.003% of average net assets)
JNGLX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Jefferies LLC | $206K | 20.20% |
| Merrill Lynch, Pierce, Fenner & Smith Inc. | $154K | 15.15% |
| JP Morgan Securities LLC | $134K | 13.10% |
| Goldman Sachs & Co. LLC | $133K | 13.00% |
| Morgan Stanley | $91K | 8.90% |
| UBS Securities LLC | $70K | 6.88% |
| Liquidnet, Inc. | $66K | 6.47% |
| Cowen and Company | $58K | 5.64% |
| Citigroup Global Markets Inc. | $56K | 5.47% |
| William Blair & Company, LLC | $53K | 5.20% |
JNGLX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| JP Morgan Securities LLC | $83.2M | 45.79% |
| Merrill Lynch, Pierce, Fenner & Smith Inc. | $24.8M | 13.64% |
| Barclays Capital Inc. | $18.5M | 10.16% |
| Morgan Stanley | $16.7M | 9.17% |
| Cowen and Company | $15.3M | 8.41% |
| Goldman Sachs & Co. LLC | $9.9M | 5.42% |
| Jefferies LLC | $5.3M | 2.89% |
| Nomura Securities International, Inc. | $3.1M | 1.68% |
| Mizuho Securities USA LLC | $2.7M | 1.47% |
| Piper Jaffray & Co. | $2.5M | 1.36% |
Janus Henderson Global Life Sciences Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| JFNNX | Class N | 0.68% | none |
| JFNIX | Class I | 0.78% | none |
| JNGLX | Class D | 0.81% | — |
| JAGLX | Class T | 0.92% | none |
| JFNAX | Class A | 1.00% | 5.75% |
| JFNSX | Class S | 1.19% | none |
| JFNCX | Class C | 1.79% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.